Measurement of Glycaemic Responses of Bakery and Confectionery Products (GIFA)

This study has been completed.
Sponsor:
Collaborator:
Fazer Bakeries Ltd.
Information provided by (Responsible Party):
Clinical Life Sciences Ltd.
ClinicalTrials.gov Identifier:
NCT01454219
First received: October 14, 2011
Last updated: February 14, 2012
Last verified: November 2011
  Purpose

This study aims to determine the glycemic index, glycemic load and insulin index of eleven Fazer bakery and confectionary products.


Condition Intervention
Healthy
Other: Bakery and confectionary products

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Measurement of Glycaemic Responses of Bakery and Confectionery Products

Resource links provided by NLM:


Further study details as provided by Clinical Life Sciences Ltd.:

Primary Outcome Measures:
  • Glycemic index (GI) [ Designated as safety issue: No ]
    The 2 hours glycemic responses to bakery and confectionery products (the incremental area under the glucose response curve, IAUC).


Secondary Outcome Measures:
  • Insulin index (II) [ Designated as safety issue: No ]
    The 2 hours insulinemic responses to bakery and confectionery products (the incremental area under the insulin response curve, IAUC).

  • Glycemic load (GL) [ Designated as safety issue: No ]

Enrollment: 14
Study Start Date: August 2011
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Bakery and confectionary products
    Control product: Glucose solution, Test products: 11 bakery and confectionary products
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • voluntarily given written consent for participation in research
  • healthy man or women, age between 18 ang 65 years
  • regular eating
  • Body Mass Index 18,5 - 24,9 kg/m2

Exclusion Criteria:

  • diabetes
  • gastrointestinal diseases
  • hepatic, kidney, pancreas or thyroid disease or disorder
  • arthritis
  • pregnancy or breast feeding
  • smoking
  • allergy
  • severe diseases
  • blood donation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01454219

Locations
Finland
Clinical Life Sciences Ltd
Kajaani, Finland, 87100
Sponsors and Collaborators
Clinical Life Sciences Ltd.
Fazer Bakeries Ltd.
Investigators
Principal Investigator: Päivi Cheney, MD
Study Director: Tiina Suutari, M.Sc. Clinical Life Sciences Ltd.
  More Information

No publications provided

Responsible Party: Clinical Life Sciences Ltd.
ClinicalTrials.gov Identifier: NCT01454219     History of Changes
Other Study ID Numbers: GIFA
Study First Received: October 14, 2011
Last Updated: February 14, 2012
Health Authority: Finland: Ethics Committee

ClinicalTrials.gov processed this record on October 23, 2014